Use of guideline-directed medical therapy for secondary prevention after MI has improved over time in older adults, though the oldest patients (>=80 years) remain undertreated.
Preventive therapy uptake after MI is rising in older adults; extends temporal trends but leaves open targeted strategies for those aged >=80 years.
Secondary preventive drug treatment in patients aged > or =60 years with a history of myocardial infarction was investigated for age-dependent differences in time trends. Sixteen general practices in the Netherlands participated. Preventive treatment with at least three of four drugs (antithrombotics, statins, beta-blockers, and/or angiotensin-converting enzyme inhibitors) increased significantly over time in all three age strata of older patients. Although the greatest relative increase (2.2 times greater) took place in patients aged > or =80 years, these patients consistently had most room for improvement.
No takes yet. Share an insight, caveat, or question.
Ruijter et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: